HomeBTAI • NASDAQ
BioXcel Therapeutics Inc
add
$1.39
2.11%
After Hours:(2.88%)-0.040
$1.35
Closed: May 21, 4:56:02 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 168.00K | -71.13% |
Operating expense | 10.25M | -58.43% |
Net income | -7.25M | 72.92% |
Net profit margin | -4.32K | 6.20% |
Earnings per share | -1.50 | 89.22% |
EBITDA | -10.02M | 58.38% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.01M | -58.17% |
Total assets | 38.57M | -53.15% |
Total liabilities | 128.74M | -16.77% |
Total equity | -90.17M | — |
Shares outstanding | 6.06M | — |
Price to book | -0.09 | — |
Return on assets | -65.66% | — |
Return on capital | -197.63% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.25M | 72.92% |
Cash from operations | -12.04M | 31.98% |
Cash from investing | — | — |
Cash from financing | 13.20M | -50.42% |
Net change in cash | 1.16M | -87.01% |
Free cash flow | -9.70M | 1.01% |
Previous close
$1.42
Day range
$1.36 - $1.48
Year range
$1.29 - $33.62
Market cap
8.42M USD
Avg Volume
92.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
37
